Lite Strategy, Inc. — Director's Dealing 2021

Nov 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2021-11-22

Reporting Person: KANGO SUJAY (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-22	Stock Option (Right to Buy)	$2.69	A	58334	Acquired	2031-11-22	Common Stock (58334)	Direct

Footnotes

F1: 25,000 options will vest in equal monthly installments over thirty-six months from November 22, 2021 and 33,334 options shall vest in equal monthly installments over twelve months from November 22, 2021.